Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Belite Bio Presented Final Data From A 24-month, Phase 2 Study Of Tinlarebant In In Childhood-onset Stargardt Disease At The American Association Of Ophthalmology Annual Meeting

Author: Benzinga Newsdesk | November 06, 2023 09:05am

Posted In: BLTE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist